University of Southern California
USC Norris Comprehensive Cancer Center
If you are a patient, please contact Keck Medical Center of USC at 800-USC-CARE.

Trial 4P-12-7

Immune Monitoring Protocol in Men with Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-T.

Type: Other
Phase: Not Applicable
Status: Not Open (Closed)
Randomized: No
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  David Quinn, M.D.
Other Trial Staff:  Charlean Ketchens, R.N., Lagrimas Ilagan, D.M., Roberto Tejada, D.M., Yvette Viverette, R.N.

Staff may log in to see study documents.

You may participate in this study if:
1All men who are enrolled in a clinical trial of Sipuleucel-T (including a Dendreon-sponsored clinical trial or registry, or an IIT) and have not yet undergone leukapheresis for their first dose of Sipuleucel-T.

For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3111.